Versant Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$717K Sell
1,980
-672
-25% -$230K 0.06% 190
2026
Q1
$933K Buy
2,652
+485
+22% +$173K 0.09% 137
2025
Q4
$709K Buy
2,167
+119
+6% +$37.7K 0.09% 145
2025
Q3
$578K Buy
2,048
+512
+33% +$148K 0.08% 168
2025
Q2
$429K Sell
1,536
-281
-15% -$79.6K 0.07% 218
2025
Q1
$566K Buy
1,817
+594
+49% +$175K 0.1% 130
2024
Q4
$319K Buy
1,223
+156
+15% +$46.3K 0.07% 132
2024
Q3
$344K Buy
1,067
+116
+12% +$37.9K 0.08% 107
2024
Q2
$297K Sell
951
-13
-1% -$3.82K 0.08% 103
2024
Q1
$274K Buy
964
+32
+3% +$9.36K 0.08% 106
2023
Q4
$268K Sell
932
-12
-1% -$3.27K 0.08% 107
2023
Q3
$254K Buy
944
+3
+0.3% +$749 0.08% 108
2023
Q2
$209K Sell
941
-176
-16% -$40.8K 0.07% 121
2023
Q1
$270K Buy
1,117
+23
+2% +$5.65K 0.09% 100
2022
Q4
$287K Buy
1,094
+2
+0.2% +$536 0.1% 81
2022
Q3
$246K Buy
1,092
+1
+0.1% +$242 0.1% 90
2022
Q2
$265K Hold
1,091
0.1% 91
2022
Q1
$264K Buy
1,091
+646
+145% +$148K 0.08% 94
2021
Q4
$100K Sell
445
-6
-1% -$1.27K 0.03% 156
2021
Q3
$96K Sell
451
-11
-2% -$2.53K 0.03% 154
2021
Q2
$113K Sell
462
-126
-21% -$31K 0.04% 133
2021
Q1
$146K Buy
588
+3
+0.5% +$716 0.05% 125
2020
Q4
$134K Hold
585
0.05% 125
2020
Q3
$148K Hold
585
0.07% 111
2020
Q2
$138K Buy
585
+3
+0.5% +$684 0.06% 113
2020
Q1
$117K Sell
582
-53
-8% -$11.6K 0.06% 115
2019
Q4
$153K Sell
635
-5
-0.8% -$1.1K 0.08% 96
2019
Q3
$123K Buy
640
+22
+4% +$4.22K 0.06% 111
2019
Q2
$113K Sell
618
-214
-26% -$38.3K 0.05% 116
2019
Q1
$158K Buy
832
+17
+2% +$3.25K 0.07% 109
2018
Q4
$158K Hold
815
0.07% 103
2018
Q3
$168K Sell
815
-2
-0.2% -$394 0.07% 104
2018
Q2
$150K Hold
817
0.06% 112
2018
Q1
$139K Sell
817
-3
-0.4% -$551 0.06% 120
2017
Q4
$142K Buy
820
+38
+5% +$6.72K 0.06% 118
2017
Q3
$145K Sell
782
-137
-15% -$24.3K 0.08% 95
2017
Q2
$158K Hold
919
0.09% 87
2017
Q1
$150K Hold
919
0.08% 95
2016
Q4
$134K Sell
919
-45
-5% -$6.77K 0.08% 100
2016
Q3
$160K Sell
964
-25
-3% -$4.23K 0.09% 90
2016
Q2
$150K Sell
989
-23
-2% -$3.58K 0.09% 90
2016
Q1
$151K Sell
1,012
-28
-3% -$4.16K 0.09% 89
2015
Q4
$168K Buy
+1,040
New +$163K 0.11% 81

Other funds holding AMGN

Versant Capital Management's AMGN Position: Q2 2026 in Review

Versant Capital Management reduced its Amgen (AMGN) stake by 25% in Q2 2026, selling an estimated $230K and leaving 1,980 shares worth $717K. The position accounts for 0.06% of the portfolio, ranked #190.

Versant Capital Management first reported a position in AMGN in Q4 2015 and has held it in 43 quarters since. The position peaked at $933K in Q1 2026. 910 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Versant Capital Management held 1,980 shares of Amgen worth $717K as of Q2 2026.
  • Versant Capital Management sold 672 Amgen shares in Q2 2026, an estimated $230K.
  • Amgen made up 0.06% of Versant Capital Management's portfolio in Q2 2026, its #190 holding.
  • Versant Capital Management first reported a position in Amgen in Q4 2015 and has held it in 43 quarters since.
  • Versant Capital Management's Amgen position peaked at $933K in Q1 2026.
  • 910 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.